COMBRETASTATIN B-1
UNII NK47TS5H6V

Substance Identification & Data

This profile provides standardized clinical and technical data for Combretastatin B-1, uniquely identified by the FDA Unique Ingredient Identifier (UNII) NK47TS5H6V.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 109971-64-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
NK47TS5H6V
CAS Registry Number
109971-64-4
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
COMBRETASTATIN B-1
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C18H22O6
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
ZSNYQENLWQYSRK-UHFFFAOYSA-N
Line notation for describing the chemical structure and connectivity of atoms.
PubChem CID
Unique identification number in the NCBI database of chemical substances.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
O(C)c1c(OC)cc(CCc2c(O)c(O)c(OC)cc2)cc1OC

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Combretastatin B-1. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

COMBRETASTATIN B-1

Systematic Nomenclature

1,2-BENZENEDIOL, 3-METHOXY-6-(2-(3,4,5-TRIMETHOXYPHENYL)ETHYL)-
3-METHOXY-6-(2-(3,4,5-TRIMETHOXYPHENYL)ETHYL)-1,2-BENZENEDIOL